✦ LIBER ✦

Modern genetic approaches to searching for targets for medicinal preparations

✍ Scribed by S. V. Sarantseva; A. L. Schwarzman

Book ID: 110199779
Publisher: SP MAIK Nauka/Interperiodica
Year: 2009
Tongue: English
Weight: 451 KB
Volume: 45
Category: Article
ISSN: 1022-7954
DOI: 10.1134/s1022795409070011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genetic Epidemiological Approaches to th

Genetic Epidemiological Approaches to the Search for Osteoporosis Genes

✍ T. V. Nguyen; J. Blangero; J. A. Eisman 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 81 KB

A new approach to preparing students for

A new approach to preparing students for academic medicine

✍ J. M. ROSS; JANE M. WALTER; D. J. MALENKA; B. REILLY; MAGGIE MOOREWEST 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB

From traditional Ayurvedic medicine to m

From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer

✍ Aggarwal, Bharat B; Ichikawa, Haruyo; Garodia, Prachi; Weerasinghe, Priya; Sethi 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 630 KB

A genetic search approach to unfalsified

A genetic search approach to unfalsified PI control design for a weigh belt feeder

✍ Emmanuel G. Collins Jr.; Yanan Zhao; Richard Millett 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 1 views

ChemInform Abstract: Several Approaches

ChemInform Abstract: Several Approaches to the Directed Search for Medicinal Drugs on the Basis of Nicotinic Acid

✍ V. M. Kopelevich; V. I. Gunar 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB 👁 2 views

Chemical genetics approach to hepatitis

Chemical genetics approach to hepatitis C virus replication: cyclophilin as a target for anti-hepatitis C virus strategy

✍ Koichi Watashi; Kunitada Shimotohno 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB

## Abstract Hepatitis C virus (HCV) is a major causative agent of liver diseases such as chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Because the current standard therapy, interferon (IFN) or pegylated‐IFN alone or in combination with ribavirin, is ineffective on approximately h